| Choksi Laboratories Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 526546 |
NSE Symbol : - |
P/E(TTM) : 50.32 |
|
ISIN Demat : INE493D01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.37 |
|
Book Value(₹) : 35.17 |
Market Cap(₹Cr) : 83.06 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 11.12 | 11.24 | 11.40 | 10.38 | 9.26 | 10.74 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11.12 | 11.24 | 11.40 | 10.38 | 9.26 | 10.74 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.00 | 0.04 | 0.01 | 0.01 | 0.01 |
| Total Income | 11.13 | 11.25 | 11.44 | 10.39 | 9.27 | 10.74 |
| Total Expenditure | 8.19 | 8.34 | 7.90 | 7.84 | 6.90 | 7.90 |
| PBIDT | 2.94 | 2.90 | 3.55 | 2.55 | 2.37 | 2.84 |
| Interest | 0.69 | 0.60 | 0.58 | 0.69 | 0.66 | 0.72 |
| PBDT | 2.25 | 2.30 | 2.96 | 1.86 | 1.71 | 2.12 |
| Depreciation | 1.69 | 1.68 | 1.70 | 1.68 | 1.61 | 1.50 |
| Tax | 0.27 | 0.12 | 0.59 | 0.14 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.05 | 0.12 | -0.25 | -0.06 | 0.02 | 0.19 |
| Reported Profit After Tax | 0.24 | 0.39 | 0.92 | 0.11 | 0.08 | 0.42 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.24 | 0.39 | 0.92 | 0.11 | 0.08 | 0.42 |
| EPS (Unit Curr.) | 0.35 | 0.55 | 1.32 | 0.15 | 0.11 | 0.60 |
| EPS (Adj) (Unit Curr.) | 0.35 | 0.55 | 1.32 | 0.15 | 0.11 | 0.60 |
| Calculated EPS (Unit Curr.) | 0.35 | 0.55 | 1.32 | 0.15 | 0.11 | 0.60 |
| Calculated EPS (Adj) (Unit Curr.) | 0.35 | 0.55 | 1.32 | 0.15 | 0.11 | 0.60 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.39 | 2.21 | 5.29 | 0.61 | 0.43 | 2.42 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.39 | 2.21 | 5.29 | 0.61 | 0.43 | 2.42 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.44 | 25.80 | 31.14 | 24.57 | 25.59 | 26.44 |
| PBDTM(%) | 20.23 | 20.46 | 25.96 | 17.92 | 18.47 | 19.74 |
| PATM(%) | 2.16 | 3.47 | 8.07 | 1.06 | 0.86 | 3.91 |